Visioneering Technologies Inc.

We’re excited to announce our attendance at The American Academy Of Optometry annual meeting in Indianapolis on November 6-9! We invite you to join a presentation by VTI’s Chief Medical Officer, Dr.  Kuang-mon (Ashley) Tuan, as she unveils major discoveries in myopia management from our PROTECT RCT. Here are the details: • Session Title: “Accommodative Accuracy of Children Wearing Catenary Curve  Multifocal Lenses, 1-Year PROTECT Results”  • What You’ll Learn:  - High relative plus in NaturalVue has no negative impact to accommodative accuracy  - NaturalVue normalizes accommodative accuracy for kids who struggle with focus at near  • When: November 7, 8:30-8:45 AM  • Location: Indianapolis Convention Center, Room 240-242 #Academy24 #PROTECT #NaturalVue #Myopia #VTI VTI-RCT-SM11

🚨 Myopia is on the rise! 🚨 A recent study published by the British Journal of Ophthalmology revealed that 1 in 3 children worldwide is now nearsighted. This alarming trend highlights the importance of early intervention in managing myopia progression. At VTI, we are committed to addressing the rapid increase in the prevalence of myopia. Our NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses enhance vision in the short-term while managing myopia long-term. Read the full CNN article here: https://bit.ly/47JqltI #Myopia #MyopiaManagement #CNN #VTI #NaturalVue MKT-VTI-SM59

Didn’t get a chance to meet up with the VTI team at Vision by Design last week? Discover how you can redefine the patient experience with NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses, designed to accommodate a range of myopic and presbyopic patients. Learn more here: https://lnkd.in/eBTJ7ZVD We look forward to supporting your practice! #VTI #NaturalVue #MyopiaManagement

A big thank you to all the dedicated eyecare professionals who connected with us at Vision by Design in Dallas last week! It was a pleasure meeting with such a passionate group, all focused on slowing the progression of myopia and delivering better outcomes for patients. #VTI #NaturalVue #VisionByDesign #vbd2024 #MyopiaManagement #EyeCare #DallasTX #eyeonVBD VTI-RCT-SM10

VTI recently announced the publication of peer-reviewed data from a prospective clinical study with mature presbyopes in Clinical Ophthalmology. The study concluded that NaturalVue® Enhanced Multifocal provided a wide range of functional vision while maintaining clear distance vision for individuals suffering from advanced presbyopia. The article entitled, Evaluation of the Functional Visual Range of a Catenary Curve-Based, Extended Depth-of-Focus Contact Lens for Presbyopia, is available online at Clinical Ophthalmology-Dove Press website. To view the complete peer-reviewed published article, click here: https://ow.ly/iVTA50TAF24.

Visioneering Technologies Inc.’s CEO, Dr. Juan Carlos Aragon, from the International Myopia Conference in Hainan, China with Dr. Ashley Tuan, presenting VTI's latest data from the PROTECT RCT. The poster, entitled, “Optical Defocus to Influence the Progression of Myopia and Eye Growth Shows Dosage-Dependency in Children”, authored by Dr. Tuan and Dr. Sally Dillehay, shares data from the 1-Year results of the study.

Connect with VTI at Vision by Design, hosted by The American Academy of Orthokeratology and Myopia Control, from October 2-5 in Dallas, Texas! Here’s where to find us: 📍Booth #217 📊 Research Presentation: • Session Title: “Randomized Controlled Trial Corroborates Real-World Studies Data for Myopia Progression Control Using Catenary Power Profile Contact Lenses” • When: October 4, 9:40-10 AM • Where: Reunion GH 🪧 Poster Presentation: • When: October 4, 4:40-5:10 PM • Where: Reunion Foyer We look forward to connecting with you! #VTI #NaturalVue #VisionByDesign #vbd2024 #MyopiaManagement #EyeCare #DallasTX #eyeonVBD

We are excited to announce that we will be attending Vision by Design, hosted by The American Academy of Orthokeratology and Myopia Control, October 2-5 in Dallas, Texas! Join VTI/NaturalVue for exciting research updates on Friday, October 4th at 9:40-10 AM, featuring Dr. Kuang-mon (Ashley) Tuan, VTI’s Chief Medical Officer. Dr. Tuan will present “Randomized Controlled Trial Corroborates Real-World Studies Data for Myopia Progression Control Using Catenary Power Profile Contact Lenses.” Later that day, don’t miss our poster session from 4:40-5:10 PM.   Visit us at Booth #217 to discover how NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses accommodate a range of myopic and presbyopic patients. #VTI #NaturalVue #VisionByDesign #vbd2024 #MyopiaManagement #EyeCare #DallasTX #eyeonVBD

Finally, more support that myopia is a disease and should be treated as such. Check out the new report from The National Academies of Sciences, Engineering, and Medicine entitled Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease.

Do you have any new drivers in your patient base? 🚗👀 If you have any myopic teenage patients on the road for the first time, consider fitting them in NaturalVue® Enhanced Multifocal 1 Day Contact Lenses. These lenses offer an extended depth of focus and good peripheral vision, helping new drivers see clearly and stay safe in their first years behind the wheel. Understand the benefits of NaturalVue®: https://bit.ly/3RabHoa #VTI #NaturalVueEnhancedMultifocal #NewDrivers MKT-VTI-SM54 r5